Aelin Therapeutics
https://aelintx.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Aelin Therapeutics
Venture Funding Deals: Orchard Therapeutics Spreads Its Roots
Rare disease gene therapy play Orchard added new investors in an oversubscribed Series B raising $110m and therapeutic antibody developer Allakos raised $100m in its Series B round, while Obsidian raises $49.5m for next-generation cancer cell therapies in Series A.
Company Information
- Industry
-
Biotechnology
- Drug Discovery Tools
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice